The scenario
A pharmaceutical company faces repeated delays in filing new drug applications, risking market access and compliance. This analysis maps out potential root causes across multiple domains.
What is in this drawing
Read the decisions behind it.
01
Prioritize process and system improvements
02
Enhance training programs
03
Implement real-time tracking dashboards
When diagnosing delays in regulatory submissions, especially for eCTD-based filings, and aiming to identify systemic issues.
More like this